Sun, Nov 23, 2014, 11:01 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

  • bobbifleiss bobbifleiss Oct 4, 2012 11:44 AM Flag

    Yale Jen, senior biotech analyst with Roth Capital

    "If you look at the nature of data in initial studies with small patient size, once you see efficacy, that is the most important sign, (which is) very encouraging. Then you wait for larger studies to see if it is reinforced. In terms of technology, this is a simple treatment modality. If clinical results bear out, this will be a very useful approach to treat patients. Oncology has become a very important, interesting market. When I began my career, there was just one company — Bristol Myers — but now that’s changed, there’s many ways beyond chemotherapy to treat tumors. Anything that improves outcomes with less side effects is going to have a good market.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.54-0.02(-4.42%)Nov 21 4:01 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Calpine Corp.
NYSEFri, Nov 21, 2014 4:04 PM EST
Exa Corporation
NasdaqGMFri, Nov 21, 2014 3:59 PM EST
Aruba Networks, Inc.
NasdaqGSFri, Nov 21, 2014 4:00 PM EST